An experimental chemically inactivated HIV-1 vaccine induces antibodies that neutralize homologous and heterologous viruses
- 31 January 1995
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 13 (1), 54-60
- https://doi.org/10.1016/0264-410x(95)80011-2
Abstract
No abstract availableThis publication has 25 references indexed in Scilit:
- Induction of HIV-1-neutralising and syncytium-inhibiting antibodies in uninfected recipients of HIV-1IIIB rgp120 subunit vaccineThe Lancet, 1993
- Is clearance of HIV-1 viraemia at seroconversion mediated by neutralising antibodies?The Lancet, 1992
- Inactivated Whole SIV Vaccine in Macaques: Evaluation of Protective Efficacy Against Challenge with Cell-Free Virus or Infected CellsAIDS Research and Human Retroviruses, 1992
- Intrarectal challenge of macaques vaccinated with formalin-inactivated simian immunodeficiency virusThe Lancet, 1992
- Preclinical and clinical studies on immunogenicity and safety of the HIV-1 p17-based synthetic peptide AIDS vaccine — HGP-30-KLHInternational Journal of Immunopharmacology, 1991
- A Phase I Evaluation of the Safety and Immunogenicity of Vaccination with Recombinant gp160 in Patients with Early Human Immunodeficiency Virus InfectionThe New England Journal of Medicine, 1991
- Preliminary report: protection of cynomolgus macaques against simian immunodeficiency virus by fixed infected-cell vaccineThe Lancet, 1990
- Vaccine Protection of Rhesus Macaques Against Simian Immunodeficiency Virus InfectionAIDS Research and Human Retroviruses, 1990
- Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160Nature, 1990
- A Formalin-Inactivated Whole SIV Vaccine Confers Protection in MacaquesScience, 1989